Literature DB >> 15653212

Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study.

Onder Celik1, Seyma Hascalik, Kaya Sarac, M Mutlu Meydanli, Alpay Alkan, Bulent Mizrak.   

Abstract

OBJECTIVE: To assess the potential clinical utility of in vivo proton magnetic resonance spectroscopy (MRS) in patients with various endometrial lesions.
METHODS: Twelve patients with untreated uterine bleeding were included in this study. In-vivo proton MRS was performed using a 1.5 T MR scanner. The metabolite levels were classified into three classes in comparison with the noise level by visual examination. All the patients have endometrial biopsy. For each type of lesions, chemical compound were described.
RESULTS: Pathological examination resulted in three endometrial cancer, two simple hyperplasias, one complex hyperplasia, two partial hydatiform mole, two proliferative endometrium and two secretory endometrium. In women with endometrial carcinoma, high choline and lipid signals were detected, whereas no creatine and no lactate signals were found. In women with endometrial hyperplasia, choline signal was detectable in all cases but one case showed lactate signal in addition to choline. In women with partial hydatidiform mole, the only detectable signal was choline. Lipid signals were detected in none of the cases with endometrial hyperplasia and partial hidatidiform mole. In women with either secretory or proliferative endometrium, choline and lactate signals were detectable in all cases but one case showed solely choline. Lipid signals were not detected in any of subjects with secretory or proliferative endometrium.
CONCLUSION: The observed difference is the presence of lipid signal only in endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653212     DOI: 10.1016/j.ejogrb.2004.06.030

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

2.  Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Eur Radiol       Date:  2013-06-06       Impact factor: 5.315

Review 3.  What Is the Best Preoperative Imaging for Endometrial Cancer?

Authors:  Ingfrid S Haldorsen; Helga B Salvesen
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

4.  Testis spectroscopy may predict sperm retrieval rate in men with non-obstructive azoospermia undergoing micro-TESE: A pilot study

Authors:  Önder Çelik; Şafak Hatırnaz; Aynur Erşahin; Alper Başbuğ; Gonca Yetkin Yıldırım; Vahit Özener; Neslihan Gürpınar; Sudenaz Çelik; Nilüfer Çelik; Tansu Küçük; Cihat Ünlü
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-10-23

5.  Head-to-head comparison of [18F]-fluorodeoxyglucose and [18F]-fluorocholine positron emission tomography/computed tomography in three patients with rare gestational trophoblastic neoplasms: A case series.

Authors:  Tanyaluck Thientunyakit; Thonnapong Thongpraparn; Tossaporn Siriprapa; Juri G Gelovani
Journal:  World J Nucl Med       Date:  2019-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.